health-tech

Sequana Medical receives CE-mark approval

on 30/10/2012 13:27
Sequana Medical receives CE-mark approval for the use of its alfapump® system in cancer patients with malignant ascites
Read more

Capricorn Health-tech Fund makes its fourth investment

on 26/09/2012 11:27
Mainstay Medical completes € 15.3 million oversubscribed series B venture financing
Read more

Nexstim announces FDA clearance for NexSpeech® – enabling noninvasive speech mapping prior to neurosurgery

on 11/06/2012 17:42
NBS System now available to US patients for both motor and speech mapping of the cortex
Read more

University Hospital Zurich and University Inselspital Berne implant their first patients with Sequana Medical’s ALFApump® System

on 24/05/2012 11:08
Swiss company’s innovative technology for the management of refractory ascites significantly reduces the need for large-volume paracentesis, improving patient quality of life.
Read more

Sequana Medical’s ALFApump® System proves to be a safe and efficacious

on 20/04/2012 12:20
Data presented at the International Liver Disease Meeting demonstrated that the ALFApump System significantly decreases the need for Large Volume Paracentesis and can reduce hospital visits
Read more